Consistent with this, silencing of NCL and HNRNPA1 resulted in upregulation of CD39 only in cells that expressed high levels of CD39-AS RNA like Treg and Th17 cells derived from Crohn’s disease patients but not from healthy subjects. This evidence concerns the gene HNRNPA1 and Crohn disease.